SenzaGen Newsletter December 2024

SenzaGen Newsletter December 2024

As 2024 ends, we’re proud to share how our innovative GARD? method is addressing key challenges in skin sensitization testing. In Q4, we’ve focused on filling data gaps in areas like Medical Devices, Safe Dose Levels, and Complex Mixtures—driving the shift to reliable, human-relevant solutions:

  • Building confidence in NAMs for Biological safety testing of Medical Devices?
  • Discussing safe dose levels at ASCCT
  • Conclusive testing results for Natural Extracts

Read the full newsletter here

要查看或添加评论,请登录

SenzaGen的更多文章

社区洞察

其他会员也浏览了